Advertisement

Management of Patient with Aneurysmal Subarachnoid Hemorrhage

  • Charu Mahajan
  • Indu Kapoor
  • Hemanshu Prabhakar
Chapter
  • 22 Downloads

Abstract

Aneurysmal subarachnoid hemorrhage is a neurological emergency associated with significant morbidity and mortality. The early brain injury, risk of rebleeding, systemic complications and vasospasm are the major concerns during management of such a patient. Here, we discuss in detail the case management of a patient having aneurysmal subarachnoid hemorrhage.

References

  1. 1.
    Connoly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida R, et al. Guidelines for the management of aneurysmal subarachnoid haemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.CrossRefGoogle Scholar
  2. 2.
    Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Hunt WE, Kosnik EJ. Timing and perioperative care in intracranial aneurysm surgery. Clin Neurosurg. 1974;21:79.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Report of World Federation of Neurological Surgeons Committee on a universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg. 1988;68:985.Google Scholar
  5. 5.
    Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualised by computed tomographic scanning. Neurosurgery. 1980;6:1.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, et al. Prediction of symptomatic vasospasm after subarachnoid haemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–7.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Dupont SA, Wijdicks EF, Manno EM, Lanzino G, Rabinstein AA. Prediction of angiographic vasospasm after aneurysmal subarachnoid hemorrhage: value of the Hijdra sum scoring system. Neurocrit Care. 2009;11:172–6.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid haemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systemic review and meta-analysis. Neuroradiology. 2019;61(3):247–56.  https://doi.org/10.1007/s00234-019-02161-9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neuro-surgical or neurological management. Stroke. 2001;32:1176–80.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Schmidt JM, Ko SB, Helbok R, Kurtz P, Stuart RM, Presciutti M. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis and poor grade subarachnoid haemorrhage. Stroke. 2011;42:1351–6.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Ibrahim GM, Fallah A, Macdonald RL. Clinical, laboratory and radiographic predictors of the occurrence of seizures following aneurysmal subarachnoid haemorrhage. J Neurosurg. 2013;119:347–52.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Raper DM, Starke RM, Komotar RJ, Allan R, Connollly ES. Seizures after aneurysmal subarachnoid haemorrhage: a systematic review of outcomes. World Neurosurg. 2013;79:682–90.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Suehiro E, Sadahiro H, Goto H, Oku F, Oka Y, Fujiyama Y, et al. Importance of early postoperative body temperature management for treatment of subarachnoid haemorrhage. J Stroke Cerebrovasc Dis. 2016;25:1482–8.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Zhang G, Zhang JH, Qin X. Fever increased in-hospital mortality after sub-arachnoid haemorrhage. Acta Neurochir Suppl. 2011;110:239–43.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Kurtz P, Helbok R, Claassen J, et al. The effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Neurocrit Care. 2016;24:118–21.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Mutoh T, Kazumata K, Terasaka S, Taki Y, Suzuki A, Ishikawa T. Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage. Stroke. 2014;45:1280–4.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care. 2012;16:212.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP. The international cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg. 1990;73:37–47.PubMedCrossRefGoogle Scholar
  20. 20.
    Pasternak JJ, McGregor DG, Lanier WL, Schroeder DR, Rusy DA, Hindman B, Clarke W, Torner J, Todd MM, IHAST Investigators. Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery. Anesthesiology. 2009;110:563–73.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Bhatia R, Hashemi P, Razzaq A, Parkin MC, Hopwood SE, Boutelle MG, Strong AJ. Application of rapid-sampling, online microdialysis to the monitoring of brain metabolism during aneurysm surgery. Neurosurgery. 2006;58(4 Suppl 2):ONS-313-20; discussion ONS-321.CrossRefGoogle Scholar
  22. 22.
    Bebawy JF, Gupta DK, Bendok BR, Hemmer LB, Zeeni C, Avram MJ, et al. Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile. Anesth Analg. 2010;110:1406–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Powers CJ, Wright DR, McDonagh DL, Borel CO, Zomorodi AR, Britz GW. Transient adenosine-induced asystole during the surgical treatment of anterior circulation cerebral aneurysms: technical note. Neurosurgery. 2010;67(2 Suppl Operative):461–70.PubMedGoogle Scholar
  24. 24.
    Hindman BJ, Bayman EO, Pfisterer WK, Torner JC, Todd MM. No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery. Anesthesiology. 2010;112:86–101.PubMedCrossRefGoogle Scholar
  25. 25.
    Todd MM, Hindman BJ, Clarke WR, Torner JC, Intraoperative Hypothermia For Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135–45.PubMedCrossRefGoogle Scholar
  26. 26.
    Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391–5.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Millikan CH. Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol. 1975;32:433–49.PubMedCrossRefGoogle Scholar
  28. 28.
    Wilson CD, Jai J, Shankar S. Diagnosing vasospasm after subarachnoid hemorrhage: CTA and CTP. Can J Neurol Sci. 2014;41:314–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Miller C, Armonda R, Participants in the International Multi-Disciplinary Consensus Conference on Multimodality Monitoring. Monitoring of cerebral blood flow and ischemia in the critically ill. Neurocrit Care. 2014;21(S2):121–8.CrossRefGoogle Scholar
  30. 30.
    Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100:12–24.CrossRefGoogle Scholar
  31. 31.
    Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124:1257–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Mir DIA, Gupta A, Dunning A, Puchi L, Robinson CL, Epstein HBAB, Sanelli PC. CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2014;35:866–71.PubMedCrossRefGoogle Scholar
  33. 33.
    Rots ML, van Putten MJAM, Hoedemaekers CWE, Horn J. Continuous EEG monitoring for early detection of delayed cerebral ischemia in subarachnoid hemorrhage: a pilot study. Neurocrit Care. 2016;24:207–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Stuart RM, Waziri A, Weintraub D, Schmidt MJ, Fernandez L, Helbok R, Kurtz P, Lee K, Badjatia N, Emerson R, Mayer SA, Connolly ES, Hirsch LJ, Claassen J. Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2010;13:355–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Patet C, Quintard H, Zerlauth JB, Maibach T, Carteron L, Suys T, et al. Bedside cerebral microdialysis monitoring of delayed cerebral hypoperfusion in comatose patients with poor grade aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2017;88:332–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid haemorrhage. N Engl J Med. 1983;308:619–24.PubMedCrossRefGoogle Scholar
  37. 37.
    Hanggi D, Etminan N, Mayer SA, Aldrich EF, Diringer MN, Schmutzhard E, NEWTON investigators. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage)]. Neurocrit Care. 2019;30:88–97.PubMedCrossRefGoogle Scholar
  38. 38.
    MacDonald RL, Higashida RT, Keller E, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.CrossRefGoogle Scholar
  39. 39.
    Tseng MY, Hutchinson PJ, Richards HK, Czosynka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial: clinical article. J Neurosurg. 2009;111:171–80.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Mees SMD, Rinkel GJE, Vandertop WP, Pablo AA, Lavados M, van Kooten F, Kuijsten HAJM, Boiten J, van Oostenbrugge RJ, Salman RA-S, van den Bergh WM. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012;380:44–9.PubMedCentralCrossRefGoogle Scholar
  41. 41.
    Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD, STASH Collaborators. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13:666–75.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, Newell D, Verweij B, Bullock MR, Baker A, Coplin W, Mericle R, Dai J, Rocke D, Muizelaar JP, Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39:1759–65.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Wolf S, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Routine management of volume status after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15:275–80.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383–91.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Kramer AH, Roberts DJ, Holodinsky J, Todd S, Hill MD, Zygun DA, Faris P, Wong JH. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. Neurocrit Care. 2014;21:275–84.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Al-Tamimi YZ, Bhargava D, Feltbower RG, et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 2012;43:677–82.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Francoeur C, Mayer SA. Management of delayed cerebral ischemia after subarachnoid haemorrhage. Crit Care. 2016;20:277–89.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Gathier CS, van den Bergh WM, van der Jagt M, et al; HIMALAIA Study Group. Induced Hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: A randomized clinical trial. Stroke. 2018;49:76–83.PubMedCrossRefGoogle Scholar
  49. 49.
    Haegens NM, Gathier CS, Horn J, Coert BA, Verbaan D, van den Bergh WM. Induced hypertension in preventing cerebral infarction in delayed cerebral ischemia after subarachnoid hemorrhage. Stroke. 2018;49:2630–6.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Crespy T, Heintzelmann M, Chiron C, Vinclair M, Tahon F, Francony G, Payen JF, et al. Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage? J Neurosurg Anesthesiol. 2019;31(3):323–9.  https://doi.org/10.1097/ANA.0000000000000527.CrossRefPubMedGoogle Scholar
  52. 52.
    Lannes M, Zeiler F, Guichon C, Teitelbaum J. The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review. Can J Neurol Sci. 2017;44:152–60.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Diringer MN, Bleck TP, Claude Hemphil J, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES, Citerio G, Gress D, Hanggi D, et al. Critical care management of patients following aneurysmal subarachnoid haemorrhage: recommendations from the neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Charu Mahajan
    • 1
  • Indu Kapoor
    • 1
  • Hemanshu Prabhakar
    • 1
  1. 1.Department of Neuroanesthesiology and Critical CareAll India Institute of Medical Sciences (AIIMS)New DelhiIndia

Personalised recommendations